The Weight-Loss Shot That Cut Heavy Drinking: Inside the Lancet Trial

The Weight-Loss Shot That Cut Heavy Drinking: Inside the Lancet Trial

Weekly semaglutide cut heavy drinking days by forty-one percent in a Lancet randomized trial of adults with alcohol use disorder and obesity.

Source

Weight-loss drug reduces alcohol consumption, study finds — The Pharmacist, reporting Klausen et al., The Lancet, 2026

Join the Recovered Life Community here!

What is Recovery News | Mental Health & Addiction Recovery?

Mental Health & Addiction Recovery News.